Mostrando 10 resultados de: 15
Publisher
The Lancet Infectious Diseases(4)
Nature Communications(2)
BMC Medicine(1)
Ciencia e Saude Coletiva(1)
International Journal of Epidemiology(1)
Área temáticas
Medicina y salud(9)
Medicina forense; incidencia de enfermedades(8)
Problemas sociales y servicios a grupos(5)
Enfermedades(4)
Farmacología y terapéutica(4)
Origen
scopus(15)
CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study
ArticleAbstract: Background: More doses of CoronaVac have been administered worldwide than any other COVID-19 vaccinePalabras claves:covid-19, Inactivated vaccine, pregnant women, SARS-COV-2, Vaccine effectivenessAutores:Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Pinto Júnior E.P., Rodrigues L.C., Werneck G.L., Wong K.L.M.Fuentes:scopusDuration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
ArticleAbstract: To date, no information has been published on the effectiveness of inactivated whole-virus COVID-19Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusEffectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil
OtherAbstract:Palabras claves:Autores:Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Florentino P.T.V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Rodrigues L.C., Werneck G.L.Fuentes:scopusEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
ArticleAbstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARSPalabras claves:Autores:Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.Fuentes:scopusEffectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study
ArticleAbstract: Background AU Brazil: and Scotland have used mRNA boosters in their respective : populations since SPalabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Rudan I., Sanchez M., Shah S.A., Sheikh A., Werneck G.L.Fuentes:scopusInequality and leprosy in Northeast Brazil: An ecological study
ArticleAbstract: Background. Leprosy is an important Public health problem in many developing countries and many featPalabras claves:Brazil, Ecological study, Ineguality, LeprosyAutores:Feldmeier H., Mauricio L. Barreto, Montenegro A., Pontes L.R.F.S.K., Werneck G.L.Fuentes:scopusInfluence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study
ArticleAbstract: Background: Aging influences COVID-19 severity and response to vaccination, but previous vaccine effPalabras claves:CoronaVac, covid-19, EFFECTIVENESS, Vaccine, VaxzevriaAutores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Barros J.V., Flores-Ortiz R.J., Ichihara M.Y.T., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Oliveira V.D.A., Penna G.O., Pescarini J.M., Werneck G.L.Fuentes:scopusMethods to evaluate covid-19 vaccine effectiveness, with an emphasis on quasi-experimental approaches
ArticleAbstract: The evaluation of vaccine effectiveness is conducted with real-world data. They are essential to monPalabras claves:Causal inference, CORONAVIRUS, ImmunizationAutores:Alves F.J.O., Boaventura V.S., Cruz E.P., Da Silva N.B., Falcao I.R., Ferreira A.J.F., Ichihara M.Y.T., Kerr L.R.S., Mauricio L. Barreto, Netto M.B., Oliveira V.D.A., Ortelan N., Ortiz R.F., Pescarini J.M., Pinto Júnior E.P., Pinto P.F.P.S., Ribeiro-Silva R.D.C., Rocha A.S., Saavedra R.d.C., Teixeira C.S.S., Werneck G.L.Fuentes:scopusTwo-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
ArticleAbstract: Background: Reports suggest that COVID-19 vaccine effectiveness is decreasing, but whether this reflPalabras claves:Autores:Agrawal U., Amele S., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Docherty A.B., Flores-Ortiz R.J., Katikireddi S.V., Mauricio L. Barreto, McCowan C., McMenamin J., Moore E., Oliveira V.D.A., Pan J., Ritchie L.D., Robertson C., Rudan I., Shah S.A., Sheikh A., Shi T., Simpson C.R., Taylor B., Vasileiou E., Werneck G.L.Fuentes:scopusVaccination plus previous infection: protection during the omicron wave in Brazil
OtherAbstract:Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Florentino P.T.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopus